Manufacturers Life Insurance Company, The Viking Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

$108 Billion
Q3 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 24,630 shares of VKTX stock, worth $835,695. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,630

Previous 20,474 20.3%

Holding current value

$835,695

Previous $1.09 Million 43.69%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$49.84 - $70.47 $207,135 - $292,873	4,156 Added 20.3%	24,630 $1.56 Million
Q2 2024 Aug 14, 2024	SELL	$47.39 - $80.2 $1.62 Million - $2.74 Million	-34,180 Reduced 62.54%	20,474 $1.09 Million
Q1 2024 May 14, 2024	BUY	$17.4 - $94.5 $131,909 - $716,404	7,581 Added 16.1%	54,654 $4.48 Million
Q4 2023 Feb 13, 2024	SELL	$9.24 - $19.64 $8,981 - $19,090	-972 Reduced 2.02%	47,073 $876,000
Q3 2023 Nov 15, 2023	BUY	$10.92 - $16.0 $120,655 - $176,784	11,049 Added 29.87%	48,045 $531,000
Q2 2023 Aug 11, 2023	BUY	$14.84 - $24.79 $77,257 - $129,056	5,206 Added 16.38%	36,996 $599,000
Q2 2022 Aug 15, 2022	SELL	$2.11 - $3.15 $67,076 - $100,138	-31,790 Closed	0 $0
Q1 2022 Aug 11, 2023	BUY	$3.0 - $4.88 $95,370 - $155,135	31,790 New	31,790 $95,000
Q1 2022 May 20, 2022	SELL	$3.0 - $4.88 $24,537 - $39,913	-8,179 Reduced 20.46%	31,790 $95,000
Q4 2021 Feb 16, 2022	BUY	$4.6 - $6.72 $2,925 - $4,273	636 Added 1.62%	39,969 $184,000
Q3 2021 Nov 12, 2021	SELL	$5.58 - $7.04 $15,244 - $19,233	-2,732 Reduced 6.49%	39,333 $247,000
Q2 2021 Aug 12, 2021	BUY	$5.19 - $6.73 $10,618 - $13,769	2,046 Added 5.11%	42,065 $252,000
Q1 2021 May 03, 2021	SELL	$5.74 - $9.67 $9,976 - $16,806	-1,738 Reduced 4.16%	40,019 $253,000
Q4 2020 Feb 12, 2021	BUY	$5.3 - $6.71 $9,831 - $12,447	1,855 Added 4.65%	41,757 $235,000
Q2 2020 Aug 10, 2020	SELL	$4.35 - $8.08 $10,205 - $18,955	-2,346 Reduced 5.55%	39,902 $290,000
Q1 2020 May 15, 2020	BUY	$3.45 - $7.95 $8,480 - $19,541	2,458 Added 6.18%	42,248 $198,000
Q4 2019 Feb 14, 2020	SELL	$6.38 - $8.73 $10,080 - $13,793	-1,580 Reduced 3.82%	39,790 $319,000
Q2 2019 Aug 14, 2019	BUY	$7.67 - $10.63 $4,402 - $6,101	574 Added 1.41%	41,370 $343,000
Q1 2019 May 13, 2019	BUY	$7.58 - $9.94 $39,825 - $52,224	5,254 Added 14.78%	40,796 $406,000
Q4 2018 Feb 14, 2019	BUY	$7.16 - $16.21 $12,300 - $27,848	1,718 Added 5.08%	35,542 $272,000
Q3 2018 Nov 14, 2018	BUY	$9.7 - $19.65 $4,811 - $9,746	496 Added 1.49%	33,824 $589,000
Q2 2018 Aug 14, 2018	BUY	$3.88 - $12.74 $123,919 - $406,890	31,938 Added 2297.7%	33,328 $316,000
Q1 2018 May 15, 2018	BUY	$4.11 - $6.93 $5,712 - $9,632	1,390 New	1,390 $6,000

Others Institutions Holding VKTX

# of Institutions

466

Shares Held

63.8M

Call Options Held

5.76M

Put Options Held

3.4M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $2.6B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account

Manufacturers Life Insurance Company, The Viking Therapeutics, Inc. Transaction History